GSK Articles
Synta gets $25M milestone under elesclomol accord with GSK
20 October 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
Japan sees growth in nicotine patch market
13 October 2008
World neglected tropical disease round-up
13 October 2008
Speculation that GSK may acquire Genmab
13 October 2008
Celldex gets $10M milestone
13 October 2008
GSK Paxil settlement
13 October 2008
US and UK Prix Galien awards 2008, winners announced
6 October 2008
GSK purchases 3% stake in Addex
6 October 2008
Stock Commentary - Europe - week to Sept 29, 2008
6 October 2008
UPDATE: $3 billion for global malaria campaign
6 October 2008
GlaxoSmithKline to axe 850 R&D staff
6 October 2008
Belgium launches pharma R&D campaign
6 October 2008
TRIPs mechanism set to fail as Apotex ships ARV
29 September 2008
UK's NICE says "Yes" to some drugs
29 September 2008
GSK/XenoPort submit NDA for Solzira
22 September 2008
Stock Commentary - Europe - week to Sept 15, 2008
22 September 2008
Zometa cuts risk of early-stage breast cancer recurrence
22 September 2008
Sanofi CEO reshuffle to cost 17M euros
22 September 2008
Retail drug sales in year to July 2008
22 September 2008
US
22 September 2008
Bayer tops most-visited European pharma web sites
22 September 2008
Pharmacopeia gets GSK milestone
22 September 2008
New Prepandrix data from GSK
22 September 2008
Two new indications for Merck & Co's HPV vacc
22 September 2008
Investors lay new path for Sanofi-Aventis
22 September 2008
GSK's bird flu vacc on fast-track in Japan
15 September 2008
GSK appoints Ellen Strahlman as CMO
15 September 2008
Stock Commentary - Europe - week to Sept 8, 2008
15 September 2008
Cellzome enters $25M kinase alliance with GSK
15 September 2008
Astellas looking to overtake Takeda's leading share of home market with newer products
15 September 2008
GSK return rights to Entereg to Adolor
15 September 2008
Wales begins HPV vaccination program
8 September 2008
Stock Commentary - New York week to Sept 1, 2008
8 September 2008
GSK offers employers Relenza flu vaccine option
8 September 2008
UPDATE: GSK signs upto $670M deal for retigabine
8 September 2008
GSK's darapladib prevents necrotic core expansion
8 September 2008
Pronova/GSK's Omacor reduces death in CHF patients
8 September 2008
Genmab's loss deepens in first half of 2008
8 September 2008
Control of Pierre Fabre goes to Foundation
8 September 2008
JP Garnier returning to pharma scene?
8 September 2008
US uninsured numbers down, PhRMA calls for reforms
8 September 2008
Skyepharma further reduces loss in first half
8 September 2008
China's hep B market $800M by 2012
8 September 2008
Study finds co-payment rises affect therapy compliance
1 September 2008
GSK and Valeant collaborate over retigabine
1 September 2008
Genmab plans to initiate four ofatumumab studies
1 September 2008
Genmab reaches next GSK milestone
1 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
Ligand reports second quarter in loss
1 September 2008
US seasonal flu vaccine ships early
1 September 2008
Qiagen introduces HLA-B*5701 test
1 September 2008
Biota defends Relenza settlement with GSK
1 September 2008
GSK to begin shipping flu shots to USA
18 August 2008
Stock Commentary - Europe - week to Aug 11, 2008
18 August 2008
Retail drug sales in year to June 2008
18 August 2008
Teva's 2nd-qtr 2008 profit up 5% to $539M
18 August 2008
GSK's Epzicom comparable to Truvada
18 August 2008
After database review, GSK says D:A:D study "inconclusive"
18 August 2008
Stock Commentary - Europe - week to Aug 4, 2008
11 August 2008
GSK to decide soon on Exelixis drug option
11 August 2008
2008/9 flu vaccines approved by US FDA
11 August 2008
Ofatumumab sees positive Ph III CLL data
11 August 2008
Intellego expands expertise with Zenosis acquisition
11 August 2008
UK volume price plan for GSK's Tyverb
11 August 2008
India generic firm launches 20 copycat drug names
4 August 2008
JPMA think-tank views China's appeal
4 August 2008
Retail drug sales in year to May 2008
4 August 2008
GSK's abacavir gets HSR warning from US FDA
4 August 2008
Retail drug sales in year to April 2008
28 July 2008
Stock Commentary - Europe - week to July 21, 2008
28 July 2008
Teva debuts first generic Lamictal
28 July 2008
UK to expand HPV vaccine program
28 July 2008
GSK settles Relenza dispute for A$20M
28 July 2008
Stock Commentary - Europe - week to July 14, 2008
21 July 2008
Eight drugs get nod from EMEA's COMP
21 July 2008
GSK consults with health care officials on pipeline
21 July 2008
Glycemic control data added to Avandia label
21 July 2008
GSK to close Crawley, UK, facility in 2011
21 July 2008
"Unfounded" claims, but GSK exec quits Ofsted
21 July 2008
Clarification: GSK OTC smoking cessation drug
14 July 2008
3 month delay for approval of Ligand/GSK's Promacta
14 July 2008
South Africa DoH's $468M tender for ARVs
14 July 2008
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
